A recent study reveals that patients who discontinue popular weight-loss injections like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who end conventional lifestyle regimens.
Research printed in a leading medical journal points out that while obese individuals frequently drop a large proportion of their body weight while on the medication, the mass comes back at an estimated rate of 0.8 kg per month after stopping.
"Individuals buying such treatments should be informed of the danger of rapid rebound weight gain when the therapy concludes," cautioned expert Dr. Susan Jebb.
This pace of regain means a reversion to pre-treatment mass within about a year and a half.
Analyzing Approaches
The research, which reviewed dozens of studies involving over 9,000 of patients, compared the results of these new drugs with older methods.
Researchers note that people who lose weight through dieting generally have a slower weight regain—perhaps 100 grams monthly—post-intervention.
Understanding the Fast Regain
Doctors believe the mechanism of the jabs is key to understanding the accelerated weight return.
These medications imitate a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural hormone, and could lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher.
"Stopping of this GLP-1 'fix' results in hunger is unsuppressed, making overeating much more probable."
A Lifelong Issue?
Medical guidelines suggest the injections for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.
Professionals say that, due to the likelihood of weight regain, the therapy might need to be life-long.
This view is reinforced by drug manufacturers, who state that the findings "highlight the long-term character of obesity," comparing it to managing diseases like diabetes.
User Testimonies
Users who have come off the medication report a intense return of appetite.
"I experienced something that goes on and you become extremely hungry," said one woman.
The struggle is worsened if individuals have not established sustainable lifestyle or habit modifications during treatment.
Widespread Interest
Survey data indicate that millions of people in the UK have tried weight-loss jabs in the last 12 months, with demand being substantial.
- Use is higher among women compared to males.
- The middle-aged demographic shows the greatest level of interest.
- Many obtain the medications through private healthcare rather than public health services.
Finally, clinicians stress that while these medications are potent agents for weight loss, they are not a standalone fix and long-term success hinges on ongoing behavioural changes.
